At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,100 enrolled
Drug / intervention
Covid-19 Antibody testing (IgG and IgM) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Seroprevalence of SARS-Cov-2 Antibodies in Children - a Prospective Multicentre Cohort Study
In Brief
An observational study evaluating Covid-19 Antibody testing (IgG and IgM) and Blood Storage for COVID and 2 related conditions. Completed, enrolled 1,100 participants across 5 sites.
Detailed Summary
It is unknown what proportion of healthy children have been exposed to SARS-Cov-2 and how many have antibodies. The aim of this study is to follow a cohort of healthy children over six months and measure their antibodies to SARS-CoV-2.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
CollaboratorsBelfast Health and Social Care Trust
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartMay 2020
Primary CompletionDec 2021
Study CompletionNov 2023
TodayJul 2026
First PostedApr 15, 2020
Enrollment StartMay 6, 2020
Primary CompletionDec 1, 2021
Study CompletionNov 14, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.2 years ago
Interventions
Covid-19 Antibody testing (IgG and IgM)other
Antibody testing for previous exposure to Covid-19
Blood Storageother
Storage of blood for multi-omics analysis